Cerebral venous sinus thrombosis as a complication of COVID-19 infection - A case report

• Published in: Annals of medicine and surgery (2012) Vol. 74; p. 103326
• Main Authors: Rajbhandari, Suyasha, Rajbhandari, Saujanya, Chandra, Avinash, Gurung, Pritam, Rajbhandari, Pravesh, Pant, Basant
• Format: Report
• Language: English
• Published: 01-02-2022
• ISSN: 2049-0801; 2049-0801
• DOI: 10.1016/j.amsu.2022.103326

INTRODUCTION AND IMPORTANCESevere acute respiratory distress syndrome coronavirus 2 is the causative agent of COVID-19 (Coronavirus 2019) infection. Although symptoms are usually associated with the respiratory system, its neurological involvement should not be underestimated. The most common cerebrovascular complication following the infection is ischemic stroke however, CVST (Cerebral Venous Sinus Thrombosis) has been reported. PRESENTATION OF CASEWe report a unique case of a young patient who had a history of headache and abnormal body movement immediately after COVID-19 infection. His brain Computed tomography scan and Magnetic Resonance Imaging (MRI) showed typical images of CVST. He was admitted and treated with Low Molecular weight heparin. DISCUSSIONCVST is a rare form of stroke which may have devastating complications. The diagnosis is clinically challenging due to its non-specific presentation like headache and altered sensorium alone. Inflammatory process and hypoxic state after the virus infection may favor the hypercoagulable state in CVST. Our patient did not have any other predisposing factor for a hypercoagulable state other than the COVID-19 infection.MRI and venography and computed tomographic venography are the preferred modalities. The Patient is generally treated with anticoagulation therapy. CONCLUSIONHigh index of suspicion of CVST is necessary when a patient presents with unexplained neurological manifestation following a recent COVID-19 infection to prevent from life-threatening complications. Furthermore, clinicians should not underestimate the multisystem involvement of COVID-19.